alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
EXECUTIVE OFFICE OF THE PRESIDENT

OFFICE OF THE UNITED STATES TRADE REPRESENTATIVE

WASHINGTON, D.C. 20508

December 28, 2018

RE: Product Exclusion Request Number: USTR-2018-0025-1964

Braeburn Systems LLC: 

I am pleased to notify you that the United States Trade Representative has determined to 

grant the above-referenced exclusion request submitted pursuant to the notice published at 83 FR 

32181 (‘July 11 notice’). The exclusion determination is set out in a formal notice which has 

been submitted to Office of the Federal Register for publication (‘the exclusion notice’). A prepublication version of the exclusion notice has been posted on the USTR website, at 

https://ustr.gov/sites/default/files/enforcement/301Investigations/12.21.18_Notice_of_Product_E

xclusions.pdf. 

The scope of the exclusion is governed by the formal HTSUS language in the annex to 

the product exclusion notice, and not by the product descriptions set out in any particular request 

for exclusion. An exclusion in response to your request has been granted by excluding from the 

additional tariffs products covered by a specially drafted description contained in the annex to 

the product exclusion notice. 

In accordance with the July 11 notice, the exclusion applies as of the July 6, 2018 

effective date of the tariff action, and will extend for one year after the exclusion notice is 

published in the Federal Register. As stated in the exclusion notice, U.S. Customs and Border 

Protection will issue additional instructions on entry guidance and implementation

Sincerely,

Stephen P. Vaughn

General Counsel
EXECUTIVE OFFICE OF THE PRESIDENT

OFFICE OF THE UNITED STATES TRADE REPRESENTATIVE

WASHINGTON, D.C. 20508

November 19, 2018

RE: Product Exclusion Request Number: USTR-2018-0025-2664

Reelcraft Industries:

The purpose of this letter is to inform you that the product exclusion request referenced 

above has been denied. As you are aware, USTR published a Federal Register notice (83 FR 

28710) on June 20, 2018, that announced the Trade Representative’s determination to impose an 

additional duty of 25 percent on certain products from China. On July 11, 2018, the Trade 

Representative published a Federal Register notice (83 FR 32181) which announced that a 

process had been established under which interested persons could request that products falling 

within a covered HTSUS subheading be excluded from the additional duties announced on June 

20. 

Your request was reviewed in accordance with the factors and procedures set forth in 

Section B(1) of the July 11 notice. Based on that review, and after careful consideration, your 

request was denied because the request did not contain a sufficient product identification or was 

determined to be non-administrable.

Because USTR will grant exclusion requests on a product specific basis, you may still 

benefit from a product exclusion if a similar product is granted an exclusion. Products for which 

an exclusion has been granted will be periodically announced on the USTR website. Product 

exclusions will become legally effective once published in the Federal Register. 

Sincerely,

Stephen P. Vaughn
Exhibit 31.1

CERTIFICATIONS

I, Oliver G. Brewer, certify that:
1.     I have reviewed this quarterly report on Form 10-Q of Adams Golf, Inc.;
2.     Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit
to state a material fact necessary to make the statements made, in light of the circumstances under which such
statements were made, not misleading with respect to the period covered by this quarterly report;
3.     Based on my knowledge, the financial statements, and other financial information included in this quarterly
report, fairly present in all material respects the financial condition, results of operations and cash flows of the
registrant as of, and for, the periods presented in this quarterly report;
4.      The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure
controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and
have:
       a)    designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be
designed under our supervision, to ensure that material information relating to the registrant, including
its consolidated subsidiaries, is made known to us by others within those entities, particularly during the
period in which this quarterly report is being prepared;
       b)    evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this
quarterly report our conclusions about the effectiveness of the disclosure controls and procedures, as of
the end of the period covered by this quarterly report based on such evaluation; and 
       c)    disclosed in this report any change in the registrant's internal control over financial reporting that occurred
during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an
quarterly report) that has materially affected, or is reasonably likely to materially affect, the registrant's
internal control over financial reporting; and
5.      The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal
control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of
directors (or persons performing the equivalent functions):
       a)    all significant deficiencies and material weaknesses in the design or operation of internal control over
financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process,
summarize and report financial information; and
       b)    any fraud, whether or not material, that involves management or other employees who have a significant
role in the registrant's internal controls over financial reporting.

|Date:  August 8, 2007 |  | By:/S/ OLIVER G. BREWER III          
|--------------------- |  | -------------------------------------
|                      |  | Oliver G. Brewer, III                
|                      |  | Chief Executive Officer and President
<PAGE>
                                                                    EXHIBIT 23.1

              CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS

     We consent to the incorporation by reference in this Annual Report (Form 
10-K/A) of SyQuest Technology, Inc. of our report dated December 11, 1996,
except for Note 15, paragraph 11, as to which the date is June 27, 1997,
included in the 1996 Annual Report to Shareholders of SyQuest Technology, Inc.

     We also consent to the incorporation by reference in the Registration
Statements (Form S-8 Nos. 33-46460, 33-482273, 33-99224, 33-99372) pertaining to
the 1991 Stock Option Plan, the 1992 Non-Employee Director Stock Option Plan and
the 1992 Employee Stock Purchase Plan and in the Registration Statement (Form 
S-3 No. 333-7369) of SyQuest Technology, Inc. of our report dated December 11,
1996, except for Note 15, paragraph 11, as to which the date is June 27, 1997,
with respect to the consolidated financial statements and schedule of SyQuest
Technology, Inc. included in this Annual Report (Form 10-K/A) for the year ended
September 30, 1996.


                                                     Ernst & Young LLP
                                                     -----------------
                                                     Ernst & Young LLP

San Jose, California
June 27, 1997
EXHIBIT 10.33


                        AMENDMENT TO EMPLOYMENT AGREEMENT


         This Amendment to Employment  Agreement (this  "Amendment"),  dated and
effective as of January 1, 1999, is entered into by and between Apria Healthcare
Group Inc. (the "Company") and Philip L. Carter (the "Executive").

         WHEREAS, the Company and the Executive have entered into an Employment
Agreement dated as of May 5, 1998 (the  "Employment  Agreement"); and

         WHEREAS, the Company, with the approval of its Board of Directors,  now
desires to increase the  Executive's  compensation  payable under the Employment
Agreement,  and both  parties  wish to  evidence  and confirm  such  increase by
amending  the  terms of the  Employment  Agreement  as set  forth  below in this
Amendment;

         NOW, THEREFORE, THIS AMENDMENT WITNESSETH:

         1. The first sentence of Section III A of the  Employment  Agreement is
hereby amended to read as follows:

          "The Company will pay to the Executive a base salary at the rate of 
          $600,000 per year."

         2. Clause (i) of Section III E of the  Employment  Agreement  is hereby
amended to read as follows:

          "car allowance of $12,500 per year, payable in periodic installments
           in  accordance  with the Company's customary practices,"

         3. Except as amended above,  the Employment  Agreement  shall remain in
full force and effect and, as so amended,  is hereby  ratified and  confirmed in
all respects.

         IN WITNESS WHEREOF,  the parties hereto have executed this Amendment as
of the date first above written.


    APRIA HEALTHCARE GROUP INC.           THE EXECUTIVE



By:                                    
    -------------------------------       ------------------------------  
    Ralph V. Whitworth,                   Philip L. Carter
    Chairman
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
EXHIBIT 27 -- THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED
FROM PAYLESS SHOESOURCE, INC. CONDENSED CONSOLIDATED STATEMENT OF EARNINGS FOR
THE 26 WEEKS ENDED JULY 29, 2000, AND CONDENSED CONSOLIDATED BALANCE SHEET AS OF
JULY 29, 2000, AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL
STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          FEB-03-2001
<PERIOD-START>                             JAN-30-2000
<PERIOD-END>                               JUL-29-2000
<CASH>                                          13,500<F1>
<SECURITIES>                                         0<F2>
<RECEIVABLES>                                    9,100<F3>
<ALLOWANCES>                                         0<F3>
<INVENTORY>                                    364,000
<CURRENT-ASSETS>                               435,200
<PP&E>                                       1,083,800
<DEPRECIATION>                                 588,600
<TOTAL-ASSETS>                                 970,200
<CURRENT-LIABILITIES>                          224,900
<BONDS>                                        323,700<F4>
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           200
<OTHER-SE>                                     373,500<F5>
<TOTAL-LIABILITY-AND-EQUITY>                   970,200
<SALES>                                      1,525,400<F6>
<TOTAL-REVENUES>                             1,525,400
<CGS>                                        1,026,700
<TOTAL-COSTS>                                1,026,700
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               9,600
<INCOME-PRETAX>                                127,500
<INCOME-TAX>                                    49,600
<INCOME-CONTINUING>                             77,900
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                  3,600
<CHANGES>                                            0
<NET-INCOME>                                    74,300
<EPS-BASIC>                                       2.93<F7>
<EPS-DILUTED>                                     2.90<F7>
<FN>
<F1>Includes cash equivalent securities.
<F2>Any "securities" are shown under "Cash".
<F3>Receivables are net after deduction of allowances.
<F4>Consists of Capital Lease Obligations plus Long-Term Debt.
<F5>Reflects Retained Earnings and Additional Paid In Capital.
<F6>Reflects net sales.
<F7>Expressed in dollars.
</FN>


</TABLE>
EXECUTIVE OFFICE OF THE PRESIDENT

OFFICE OF THE UNITED STATES TRADE REPRESENTATIVE

WASHINGTON, D.C. 20508

February 4, 2019

RE: Product Exclusion Request Number: USTR-2018-0025-11477

Trio Engineered Products:

The purpose of this letter is to inform you that the product exclusion request referenced 

above has been denied. As you are aware, USTR published a Federal Register notice (83 FR 

28710) on June 20, 2018, that announced the Trade Representative’s determination to impose an 

additional duty of 25 percent on certain products from China. On July 11, 2018, the Trade 

Representative published a Federal Register notice (83 FR 32181) which announced that a 

process had been established under which interested persons could request that products falling 

within a covered HTSUS subheading be excluded from the additional duties announced on June 

20.

Your request was reviewed in accordance with the factors and procedures set forth in 

Section B(1) of the July 11 notice. Based on that review, and after careful consideration, your 

request was denied because the request failed to show that the imposition of additional duties on 

the particular product would cause severe economic harm to you or other U.S. interests.

Because USTR will grant exclusion requests on a product specific basis, you may still 

benefit from a product exclusion if a similar product is granted an exclusion. Products for which 

an exclusion has been granted will be periodically announced on the USTR website. Product 

exclusions will become legally effective once published in the Federal Register. 

Sincerely,

Stephen P. Vaughn

General Counsel
EXECUTIVE OFFICE OF THE PRESIDENT

OFFICE OF THE UNITED STATES TRADE REPRESENTATIVE

WASHINGTON, D.C. 20508

March 19, 2019

RE: Product Exclusion Request Number: USTR-2018-0025-2790

Braeburn Systems LLC: 

I am pleased to notify you that the United States Trade Representative has determined to 

grant the above-referenced exclusion request submitted pursuant to the notice published at 83 FR 

32181 (‘July 11 notice’). The exclusion determination is set out in a formal notice published at 

83 FR 67463 (‘the exclusion notice’) and posted on the USTR website, at

https://ustr.gov/sites/default/files/enforcement/301Investigations/2018-28277.pdf.

The scope of your exclusion is governed by the scope of the formal HTSUS product 

description in the Annex to the exclusion notice, and not by the product descriptions set out in 

any particular request for exclusion. An exclusion in response to your request has been granted 

by excluding from the additional tariffs products covered by a specially drafted description 

contained in the Annex to the product exclusion notice. 

In accordance with the July 11 notice, the exclusion applies as of the July 6, 2018 

effective date of the tariff action, and will extend for one year after the exclusion notice is 

published in the Federal Register. As stated in the exclusion notice, U.S. Customs and Border 

Protection will issue additional instructions on entry guidance and implementation

Sincerely,

Stephen P. Vaughn

General Counsel
Exhibit 23.1





CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM





We hereby consent to the incorporation by reference in the following Registration Statements:





(1)     Registration Statement (Form S-3 No. 333-36708) of PDL BioPharma, Inc.,


(2)     Registration Statement (Form S-3 No. 333-122760) of PDL BioPharma, Inc.,


(3)     Registration Statement (Form S-3 No. 333-123958) of PDL BioPharma, Inc.,


(4)     Registration Statement (Form S-3 No. 333-128644) of PDL BioPharma, Inc.,


(5)     Registration Statement (Form S-3ASR No. 333-174052) of PDL BioPharma, Inc.,


(6)    Registration Statement (Form S-3ASR No. 333-189536) of PDL BioPharma, Inc.,


(7)     Registration Statement (Form S-8 No. 333-87957) pertaining to the 1999 Stock Option Plan and 1999


Nonstatutory Stock Option Plan of PDL BioPharma, Inc.,


(8)     Registration Statement (Form S-8 No. 333-68314) pertaining to the 1999 Stock Option Plan and 1999


Nonstatutory Stock Option Plan of PDL BioPharma, Inc.,


|    |                                                                                                                               
|--- | ------------------------------------------------------------------------------------------------------------------------------
|(9) | Registration Statement (Form S-8 No. 333-104170) pertaining to the 1999 Nonstatutory Stock Option Plan of PDL BioPharma, Inc.,

(10)     Registration Statement (Form S-8 No. 333-125906) pertaining to the 2005 Equity Incentive Plan of PDL


BioPharma, Inc., and


(11)     Registration Statement (Form S-8 No. 333-145262) pertaining to the 2005 Equity Incentive Plan of PDL


BioPharma, Inc.





of our report dated February 23, 2015, relating to the consolidated financial statements of PDL Bio Pharma, Inc., and the effectiveness of internal control over financial reporting of PDL BioPharma, Inc., which appears in this Form 10‐K originally filed on February 23, 2015.





/s/ PricewaterhouseCoopers LLP





San Jose, California


March 11, 2015
N O T FO R PUB L ICAT IO N UNITED STATES C OUR T OF APPEALS FOR THE NINTH C IR C UIT
PHILIP R OGER S,

Pe t i tione r-Appe lla

nt,
v. DEB B IE ASUNC ION, W arde n,

R e sponde nt-Appe lle e . No. 18-55102 D.C . No. 2:16-c v-00901-JC
M EM O R ANDUM *

Appe a l from

the Unite d

Stat e s Distric t C ourt for the C e ntra l Distric t of C a lifornia Ja c que line C hooljia

n, M a gistra

te Judge , Pre siding Argue d a nd Subm itte d Se pte m

be r 11, 2019 Pa sa de n a , C a l ifornia B e fore : R

AW LINSON, IKUTA, a

nd B ENNETT, C irc uit Judge s. 

# FIL ED SEP 20 2019 M OLLY C. DW Y ER, CLERK U

. S. CO URT O F APPEALS

* This disposition is not a ppropria te for public at ion a

nd is not pre c e de nt e xc e pt a s provide d

by Ninth C irc uit R

ule 36-3.Philip Ro ge rs a ppe a ls the distric t c ourt’ s de c i sion to deny his pe tition for a writ of ha be a s c orpus. 1 W e hav e jurisdic tion unde r 28 U.S.C . § 2253. R oge rs fa ile d to e s ta

blish tha t his trial c ounse l re nde re d ine ffe c tive
a ssista nc e of c ounse l unde r Stric k land v . W ashington , 466 U.S. 668, 694 (1984). Eve n if R oge rs’ s tria l c ounse l ha d introduc e d e vide nc e tha t M ary W e bste r ha d .28
m ic rogram s pe r m illiliter of c oc a ine in he r sy ste m at the tim e of the a c c ide nt, the re is not a re a sona ble proba bility tha t the re sult of theproc e e ding would ha ve be e n diffe re nt, give n the jury

wa s pre se nte d with e vide nc e tha t R oge rs ha d a

high le ve l of intoxic ation a

t t he tim e of the inc ide nt, wa s driving with a re voke d lic e n se ove r the s pe e d lim i t, a

nd ha d prior c onvic tions for both driving unde r the influe nc e of
a lc ohol a n d driving while

having 0.08% alc ohol or m ore in his blood. Furthe r supporting this c onc lusion, Roge rs fa ile d to introduc e e vide nc e tha t the c oc a ine in M s. W e b ste r’ s sy ste m

ha d a ny intoxic ating e ffe c t, a

nd the vide o foota ge of the inc i de nt pre se nte d to the jury did not show tha

t M s. W e bste r’ s m ove m e nts a t the tim e of the inc ide nt indic ate d intoxic at ion. B e c a use we c onc lude on de novo
re vie w tha

t R oge rs fa ile d to show tha t a ny de fic ie nt pe rform a

n c e of tria l c ounse l

1 W e grant R oge rs’ s m otions to ta k e judic ia l notic e of a

Google m a

p de pic ting theinte rse c tion whe re the e v e nts a t issue took pla c e and to tra nsm it to the C ourt a nd ta ke judic ia l notic e of a

vide o of the a c c ide nt introduc e d during Roge rs’ s tria l in sta te c ourt. Se eMc C

ormac k v . Hie de man , 694 F.3d 1004, 1008 n.1 (9th C ir. 2012); Harris v . C

ty . of Orange , 682 F.3d 1126, 1132 (9th C ir. 2012).

2pre

j udic e d the de fe nse , we ne e d not re a c h the que stion whe the r we a fford AEDPA de fe re nc e to the sta

te c o urt’ s de c ision. S

e e Be rghuis v . Thompk

ins , 560 U.S. 370, 389 (2010). AFFIRM E D.

3
### RECEIVED 

## Court ofAppeals .•-.;•

" *- •*• Clerk 5th District

* ^ >_^ i l^; ^ ^ -^ ^,- 

### 'J+ki:iUe, C^.ai /sf nonefits o 4 ... 

### :'•'''"' BaII^ |J^//^//9Ai 

## Th? &>»$#>«£"TfK&,!< '•;• "<i:'•'•'' ' •'' irittU D/shzV/f" or Ic^as



## ,. ;,-u,/ '"y^—s •••<, ,--- .-••- ••• •• .:. • - - V^-' -v ~\ JAW 202015 ^SaejpHulLi JgfQjxF.^f ^^J^QjQau_£jJ^jJ<^a/ a£ tine. MtsJeaf __Lt£ 

# JS_pilCpfi4,e. ibg rcfilto^fj^ ^fe^^^ M O ^^ COURTOFCRIMINALAPPEALS



# __ . ••'• '' . " -' ''' JAN 262015 Abel Acosta, Clerk

## tUSMci-Ql, 

# i tC5^ A/Ja L^i U/^Lj £lTtLAjSi£^ ,o tme. 

## UAjfil hfikth IJ.3DM. 

# The,AafleJUafk&aai h'tuq Paa ^^.tej^inc^ihiitMc tfod e£6 to 

## iMil£ sfcaaa.fcslrz%a/. ff<t CjMMhed! h Wm igajoJ; -fttofe- $?&.•fee 

# 0^tpA£idia 

# \Nhe&.th<uL, flcemt5-ej&; teMsidg.a.ed fc, Ai#il #k*f 

# (IMQtM^iL^Ams .tt/tffhL5, noMp^ialc Lu/el l^JII p 

# tHr*fc 

# ftgjftAiiMe,-.IdDu^sf .fa i^^^t;;fY?#. 

## iM> 

# li^-^x^^y "•j.^ggjii

• : ' ' • ' •• . '•;••'•>' ' • " •:" •' : " ,:.' '.•'•';;"' . -; •• • 

### • :: '- ; .'.••: : , .'"','" /'•..-' •'•.•'••' '• ',• ; ,''*.',.•.'; ••' :'- "••';..' .••..••. : . : • '

•' - - k '•..•.-• ._;./;''. ,:;'•.' ,' :;< ', ; ' ••'•' ;\: ;•' •'.-''

-

_. -..'' ' •-• 

### | j ,!,.';" . i . . ' • ; -•, '•• ! '-- / • ' ' '• • ' '''•'•' * 'NOTICE: THIS FORM CONTAINS SENSITIVE DATA. Unsworn Declaration (Texas Civil Practice and Remedies Code, Section 132.001) My name is

# :_&* Firstft KJA IVjajf Middle and 

# t \hnmpSO^I •ft my date of birth is: Month Day Year 

## myaddressis: \LQf) FM ,^V<7 J^c/^ho/Ln TtXftS IL^X IVUUi. 

# J i & i fin. and Country My email address is _ Street Address 

## J/?nk City 

### ALL State (Ifyou are incarcerated, you must also include the following information.) 

### My inmate identifying number, ifany, is: f) I <3i~I<.'l~(/77. 

### Iam presently incarcerated in: l_iAiO/SfJJ Stf/iiK J/9/1 IJaJiT , / i ^ Connections UnitName in: \MC> 

## J^I Tcx^js City County State Last lip Code
-1(^5$.

Zip Code Ideclare under penalty ofperjury that all information in the attached document titled, 

## rVflnoxf (r>4 A- [o6 Dal/ 5"*fkiin/9Afl ,istrue andcorrect. T\ Name ofDocument rr 

## IAP K County, Tzkrt S Signed in County State on this date: Month Day Year Your Signature

Pursuant to Texas Civil Practice and Remedies Code Section 132.001, an unsworn declaration may be used in lieu of a written sworn declaration, verification, certification, oath, or affidavit required by statute or required by a rule, order, or requirement adopted as provided by law. This provisiondoes not apply to an oath of office or an oath required to be taken before a specified official other than a notary public. An unsworn declaration made under this section must be 1) in writing, 2) signed by the person making the declaration as true under penalty of perjury and 3) in substantially the form used above. © TexasLawHelp.org - Unsworn Declaration, August 2012 Page 1 of 1